S. Newell

Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.

B. Kavanagh, D. Raben, Kyle E. Rusthoven, 2009, International journal of radiation oncology, biology, physics.